6NN-12232-84214 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-20
Registered in v-safe
2020-12-20
Dose 1 — Pfizer-BioNTech
2020-12-20
Health check-in — day 0, dose 1
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2020-12-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2020-12-22
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-23
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-24
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-25
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-26
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Supraclavicular lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-27
Survey response — day 7, dose 1
MedDRA: Lymphadenopathy — Feeling: Good · Be unable to do your normal daily activities

Free text: 2cm, painful supraclavicular lymphadenopathy on same side as injection

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-27
Report sent to call center — day 7, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-29
Call 2 — Left Voicemail
2021-01-10
Health check-in — day 21, dose 1
Feeling: Good

Adult check-in
2021-01-10
Call 1 — Left Voicemail
2021-01-11
Dose 2 — Pfizer-BioNTech
2021-01-18
Survey response — day 7, dose 2
MedDRA: Injection site lymphadenopathy — Feeling: Good · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness

Free text: Lymphadenopathy near injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-25
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-14
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-12
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-11
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-20	Pfizer-BioNTech
2	2021-01-11	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-27	Unsuccessful

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-26

Systemic reaction (other): Supraclavicular lymphadenopathy

Release 1 — day 7, dose 1

2020-12-27

Systemic reaction (other): 2cm, painful supraclavicular lymphadenopathy on same side as injection

Release 2 — day 7, dose 2

2021-01-18

Systemic reaction (other): Lymphadenopathy near injection site

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Injection site lymphadenopathy	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release